This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Athira Pharma, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: William R Baker: Innovator in Neurodegenerative Disease Treatment
Introduction
William R Baker is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, his work focuses on innovative methods and compounds that address various health challenges.
Latest Patents
William R Baker's latest patents include methods for treating neurodegenerative diseases using substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues. This technology encompasses compounds, kits, compositions, and methods that are beneficial for treating conditions such as dementia, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, spinal cord injury, traumatic brain injury, diabetes, metabolic syndrome, defective wound healing, and sensorineural hearing and vision loss.
Career Highlights
Baker is currently associated with Athira Pharma, Inc., where he continues to develop innovative solutions for complex medical issues. His work is characterized by a commitment to advancing therapeutic options for patients suffering from debilitating conditions.
Collaborations
Throughout his career, William R Baker has collaborated with esteemed colleagues, including Jasbir Singh and Lansing Joseph Stewart. These partnerships have contributed to the advancement of his research and the development of effective treatment methodologies.
Conclusion
William R Baker's contributions to the field of neurodegenerative disease treatment highlight his dedication to innovation and improving patient outcomes. His patents and ongoing work at Athira Pharma, Inc. reflect a significant commitment to addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile